Tech Company Financing Transactions

Avelos Therapeutics Funding Round

Mirae Asset Capital, Mirae Asset Venture Investment and SV Investment participated in a $8 million Series A capital raise for Avelos Therapeutics. The financing round was announced on 8/22/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

#325, 21 Magokjungang 8-ro 7-gil
Gangseo-gu, Seoul, Undisclosed
Republic of Korea

Phone

+82-2-6949-4369

Website

www.avelostx.com/en

Email Address

[email protected]

Overview

Excellent quality science with global standard through highly motivated scientists and outstanding leadership. Innovative biomarker-driven drug research and development of novel targeted therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Young-Whan Park

        

Chief Technical Officer

Soongyu Choi

        

VP - Bus. Development

Kangsik Yun

        

Browse more venture capital transactions:

Prev: 8/22/2022: Kasisto venture capital transaction
Next: 8/22/2022: Ubie venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary